Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 3 2

Status

Unknown 3

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 3499Neoplasms 2740Prostatic Neoplasms 1583Colorectal Neoplasms 1248Lung Neoplasms 1188Motor Activity 766Head and Neck Neoplasms 621Pancreatic Neoplasms 601Colonic Neoplasms 586Uterine Cervical Neoplasms 567Carcinoma, Non-Small-Cell Lung 560Carcinoma, Hepatocellular 559Rectal Neoplasms 516Stomach Neoplasms 493Brain Neoplasms 438Anxiety Disorders 401Ovarian Neoplasms 399Pain 376Esophageal Neoplasms 347Polycystic Ovary Syndrome 341Neoplasm Metastasis 340Fatigue 324Urinary Bladder Neoplasms 314Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 298Depression 286Multiple Myeloma 283Endometrial Neoplasms 263Lymphoma 258Hematologic Neoplasms 251

Interventions

anlotinib 2endostar protein 1Pemetrexed 1Gefitinib 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × OTHER × Non-squamous Non-small Cell Lung Cancer × Clear all
NCT04063449 2019-08-21

Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC

Third Military Medical University

Phase NA Unknown
170 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT03671538 2018-09-17

Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin

The First Affiliated Hospital of Nanchang University

Phase NA Unknown
62 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT03602027 2018-07-26

Phase I Study of the Combination of Anlotinib With Gefitinib

Second Affiliated Hospital of Nanchang University

Phase NA Unknown
9 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡